Boehringer’s Medicine Excellence initiative harnesses technology with the aim to build a ‘One Medicine Platform’, unifying development processes and data in a centralised platform.
Following her attendance at DIA Europe 2024, Humaira Qureshi from Qinecsa Solutions, discusses the historic challenges of pharmacovigilance and embracing a new future-ready ecosystem.
Just a year after it was launched, the UK’s Our Future Health research programme has signed up its millionth volunteer, a fifth of the way to its target of five million.
Health systems are being squeezed by ageing populations, overstretched health professionals, unsustainable costs and a failure to tackle disease prevention – and a new way
It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.